You are viewing the site in preview mode

Skip to main content

Advertisement

Table 1 Descriptive statistics

From: Identifying and explaining the variability in development and implementation costs of disease management programs in the Netherlands

  Mean SD Median Min Max IQR
Development duration (months) 12 6 12 3 25 6
Patients participating in DMP# 801 986 300 75 3,400 957
Organization FTEs# 433 841 33 1 2,850 256
DMP FTEs 0.76 0.58 0.60 0.10 2.50 0.63
Development costs# 75,832 72,727 49,972 5,891 274,783 85,917
Annualized development costs 69,749 47,807 48,141 7,855 198,188 66,704
Implementation costs 100,827 86,776 74,836 7,278 387,879 117,079
PACIC at baseline# (1-5 best) 2.88 0.29 2.81 2.25 3.60 0.35
PACIC at year 1# (1-5 best) 2.95 0.28 2.99 2.44 3.62 0.40
  1. #The Kolmogorov-Smirnoff test rejected the assumption of normally distributed data; SD: standard deviation; min: minimum; max: maximum; IQR: interquartile range (Quartile 3-Quartile 1); FTE: full-time equivalent; implementation costs accrued within the first calendar year of DMP implementation.